As Drug Resistance Surges, Experts Call for Antibiotics for Newborns to be Prioritised 12/12/2022 Kerry Cullinan Leading public health experts are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. Each year, there are an estimated three million cases of neonatal sepsis causing up to 570,000 deaths, many due to a current lack of effective antibiotics, according to a paper published […] Continue reading -> One in Three People Use Antibiotics Without Prescription: WHO Study of Eastern Europe, Caucasus and Central Asia 21/11/2022 Elaine Ruth Fletcher A new survey of citizens in 14 WHO member states in the Balkans, Caucasus and Central Asia found that one third of respondents questioned said that their last course of antibiotics was obtained with a medical prescription. This is at least three times more than that reported from a similar survey of 30 European Union […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Tiny Fraction of Laboratories in 14 African Countries Can Test for Antimicrobial Resistance 15/09/2022 Paul Adepoju Despite numerous announcements and plans to tackle antimicrobial resistance (AMR) in Africa, the basic requirements for testing for drug-resistant pathogens are unmet in most areas, according to a new study of 14 countries. Only 1.3% of the 50,000 medical laboratories in the participating countries are conducting routine bacteriological testing to definitively identify the type of […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
One in Three People Use Antibiotics Without Prescription: WHO Study of Eastern Europe, Caucasus and Central Asia 21/11/2022 Elaine Ruth Fletcher A new survey of citizens in 14 WHO member states in the Balkans, Caucasus and Central Asia found that one third of respondents questioned said that their last course of antibiotics was obtained with a medical prescription. This is at least three times more than that reported from a similar survey of 30 European Union […] Continue reading -> Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Tiny Fraction of Laboratories in 14 African Countries Can Test for Antimicrobial Resistance 15/09/2022 Paul Adepoju Despite numerous announcements and plans to tackle antimicrobial resistance (AMR) in Africa, the basic requirements for testing for drug-resistant pathogens are unmet in most areas, according to a new study of 14 countries. Only 1.3% of the 50,000 medical laboratories in the participating countries are conducting routine bacteriological testing to definitively identify the type of […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Answering the Challenges Posed by Antimicrobial Resistance 22/09/2022 Pascale Ondoa & Yewande Alimi Staphylococcus aureus is the source of a skin infection that can turn deadly if drug resistant. Estimates regarding the most common resistant variation, methicillin-resistant Staphylococcus aureus (MRSA), exceed 100,000 deaths globally in 2019. But up until recently, we did not have a solid grasp on how much of a problem MRSA—or any other antimicrobial resistant […] Continue reading -> Tiny Fraction of Laboratories in 14 African Countries Can Test for Antimicrobial Resistance 15/09/2022 Paul Adepoju Despite numerous announcements and plans to tackle antimicrobial resistance (AMR) in Africa, the basic requirements for testing for drug-resistant pathogens are unmet in most areas, according to a new study of 14 countries. Only 1.3% of the 50,000 medical laboratories in the participating countries are conducting routine bacteriological testing to definitively identify the type of […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tiny Fraction of Laboratories in 14 African Countries Can Test for Antimicrobial Resistance 15/09/2022 Paul Adepoju Despite numerous announcements and plans to tackle antimicrobial resistance (AMR) in Africa, the basic requirements for testing for drug-resistant pathogens are unmet in most areas, according to a new study of 14 countries. Only 1.3% of the 50,000 medical laboratories in the participating countries are conducting routine bacteriological testing to definitively identify the type of […] Continue reading -> A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A Breakthrough Tuberculosis Treatment Just Got Safer 01/09/2022 Stefan Anderson Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Not Enough Antibiotics in Drug Development – WHO’s Latest ‘Pipeline’ Report 23/06/2022 Maayan Hoffman The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR). In its annual ‘pipeline report’, which assesses those antibacterial drugs in preclinical and clinical development, WHO describes the pipeline as “stagnant” and “far from meeting […] Continue reading -> What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
What Are The Paths To A Disease-Free World And How Can We Achieve Them? 17/05/2022 Editorial team & Maayan Hoffman What are the paths health systems can take to a more disease-free world? And related to that, why do we talk about the total “eradication” of some diseases, like polio, whereas for others, “elimination as a public health problem” or simply disease “control” that shrinks an epidemic into an endemic disease is a more realistic […] Continue reading -> Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Breeding Superbugs – Veterinary Drugs, More than Human Ones, Drive AMR 04/05/2022 Elaine Ruth Fletcher Animals, not humans are the largest consumers of antimicrobial drugs – and thus the leading factor driving antimicrobial resistance. But WHO and other UN actors are still dancing around the ‘cattle, chickens and pigs’ in the room. And member states aren’t keen to track animal antibiotic use trends – even at the cost of future […] Continue reading -> Posts navigation Older postsNewer posts